- Patent Title: 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[,b,d]furan-1(9bh)-one exhibiting an inhibitory effect on human tyrosyl-DNA-phosphodiesterase 1 enzyme
-
Application No.: US16324388Application Date: 2017-07-24
-
Publication No.: US10399965B2Publication Date: 2019-09-03
- Inventor: Olga Anatolyevna Luzina , Alexandra Leonidovna Zakharenko , Dmitry Nikolaevich Sokolov , Nariman Faridovich Salakhutdinov , Olga Ivanovna Lavrik , Veniamin Abramovich Khazanov
- Applicant: INNOVATIVE PHARMACOLOGY RESEARCH OOO (IPHAR)
- Applicant Address: RU Tomsk
- Assignee: INNOVATIVE PHARMACOLOGY RESEARCH OOO (IPHAR)
- Current Assignee: INNOVATIVE PHARMACOLOGY RESEARCH OOO (IPHAR)
- Current Assignee Address: RU Tomsk
- Agency: Dergosits & Noah LLP
- Priority: RU2016132716 20160808
- International Application: PCT/RU2017/000543 WO 20170724
- International Announcement: WO2018/030916 WO 20180215
- Main IPC: C07D417/04
- IPC: C07D417/04
![2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[,b,d]furan-1(9bh)-one exhibiting an inhibitory effect on human tyrosyl-DNA-phosphodiesterase 1 enzyme](/abs-image/US/2019/09/03/US10399965B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to the field of molecular biology, biochemistry and biotechnology, namely, to compound 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl) thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-1(9bh)-one, which is a hydrazine-thiazole derivative of usnic acid of formula I and which is able to inhibit the action of human tyrosyl-DNA-phosphodiesterase 1 enzyme. Technical result: increase in inhibitory action towards human tyrosyl-DNA-phosphodiesterase 1 enzyme (Tdp1) and increase in the number of inhibitors of this enzyme. 1 independent claim, 2 figures, 3 examples.
Public/Granted literature
Information query